Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
R&D channel feed
Even as questions grow over RFK Jr.'s vaccine policy, BioNTech doesn't see ‘near-term’ impact
Last week
Pharma
FDA+
Recursion cuts nearly half of its pipeline, including its most advanced program
Last week
AI
J&J's eye disease gene therapy bota-vec fails in Phase 3 trial
Last week
Cell/Gene Tx
Early bits of in vivo CAR-T human data emerge from biotech trials in China
Last week
China
Cell/Gene Tx
Exclusive: Topas claims success in early test of 'immune tolerance' therapy for celiac disease
Last week
Exclusive: Vertex drops AAV gene therapy research, tRNA therapy partnership
2 weeks ago
Cell/Gene Tx
FDA withdraws two final guidances, pulls compliance deadlines for bone allograft makers
3 weeks ago
Pharma
FDA+
Feng Zhang’s protein nanoparticle startup Aera Therapeutics turns to lipid nanoparticles to jumpstart its pipeline
3 weeks ago
Cell/Gene Tx
Drugmakers exploit cancer’s ‘lethalities’ to make next class of targeted therapies, with first results for Werner drug
3 weeks ago
Investors unveil plans for $1.3B cancer hub in London suburbs
3 weeks ago
Manufacturing
Moderna, facing revenue misses and political headwinds, disappoints Wall Street
3 weeks ago
Pharma
CROs raise the alarm as clients delay R&D plans over funding, tariff worries
3 weeks ago
Outsourcing
Moderna expands effort to rein in costs in an ‘uncertain environment’
3 weeks ago
Pharma
Scientists alarmed about future of cancer research; TIGIT, CAR-NK and more from #AACR25
3 weeks ago
Artios drug exploits ‘replication stress’ in cancer, shrinking subset of tumors in early study
3 weeks ago
Startups
Novartis continues earnings winning streak as it raises 2025 sales expectations
3 weeks ago
Pharma
Boehringer’s updated results in HER2-mutated lung cancer impress
3 weeks ago
GSK’s checkpoint blocker Jemperli cures biomarker-driven rectal cancer
3 weeks ago
Pharma
Keytruda around head and neck cancer surgery cuts chance of disease coming back
3 weeks ago
Revolution Medicines' KRAS drug shows potential in early cut of lung cancer data
3 weeks ago
J&J reports durability data for bladder cancer 'pretzel' drug after FDA filing
3 weeks ago
FDA chief Makary talks expediting drug approvals, RIFs and the abortion pill
3 weeks ago
Pharma
FDA+
Akeso shares new data suggesting it can beat Keytruda on survival, wins China approval
3 weeks ago
China
Hoping to turn CD47 around with Keytruda combo, ALX Oncology reports two Phase 2 failures
4 weeks ago
First page
Previous page
1
2
3
4
5
Next page
Last page